Home › NDC Lookup › RxCUI directory › RxCUI 1942743

Cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection — RxCUI 1942743

Name: Cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection (RxCUI 1942743)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1942743 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1942743

Official nameCytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known ascytarabine 100 MG / daunorubicin 44 MG Liposome Injection; ara-C liposome 100 MG / Daunorubicin Liposomal 44 MG Injection

FDA products mapped1

Package NDCs mapped2

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cytarabine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Cytarabine is a chemotherapy drug used to treat certain blood cancers — specifically several forms of leukemia. These include acute non-lymphocytic leukemia, acute lymphocytic leuk...
No — cytarabine can't be taken as a pill. Your body doesn't absorb it properly through the digestive system, so it has to be given by injection. Depending on your treatment plan, t...
How is cytarabine given — do I take it as a pill?
The most expected side effects are related to the drug's effect on your bone marrow — it lowers your blood counts, which can cause fatigue from anemia, increased risk of infection,...

📖 Read our full Cytarabine guide →

🕸️ Concept Web — How Cytarabine liposome 100 MG / daunorubicin liposo... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection RxCUI 1942743 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 5

The active substance itself — no strength, form, or brand attached yet.
- Cytarabine 3041 IN
- Daunorubicin 3109 IN
- Cytarabine / daunorubicin 2017575 MIN
- Cytarabine liposome 968804 PIN
- Daunorubicin liposomal 214468 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Vyxeos 1942744 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Cytarabine / daunorubicin Injection 2285807 SCDF
- Cytarabine liposome / daunorubicin liposomal Injection 2646233 SCDFP
- Cytarabine / daunorubicin Injectable Product 2285813 SCDG
- Cytarabine liposome / daunorubicin liposomal Injectable Product 2659461 SCDGP
- Cytarabine / daunorubicin Injection [Vyxeos] 2285806 SBDF
- Cytarabine liposome / daunorubicin liposomal Injection [Vyxeos] 2654616 SBDFP
- Vyxeos Injectable Product 1942747 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 4

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Cytarabine liposome 100 MG 1942738 SCDC
- Daunorubicin liposomal 44 MG 1942739 SCDC
- Cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection [Vyxeos] 1942748 SBD
- Cytarabine liposome 100 MG / daunorubicin liposomal 44 MG [Vyxeos] 1942745 SBDC

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Cytarabine liposome 100 MG SCDC · 1942738
Daunorubicin liposomal 44 MG SCDC · 1942739
Cytarabine / daunorubicin Injection SCDF · 2285807
Cytarabine liposome / daunorubicin liposomal Injection SCDFP · 2646233
Cytarabine / daunorubicin Injectable Product SCDG · 2285813
Cytarabine liposome / daunorubicin liposomal Injectable Product SCDGP · 2659461

Brand-Name Concepts

Cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection [Vyxeos] SBD · 1942748
Cytarabine liposome 100 MG / daunorubicin liposomal 44 MG [Vyxeos] SBDC · 1942745
Cytarabine / daunorubicin Injection [Vyxeos] SBDF · 2285806
Cytarabine liposome / daunorubicin liposomal Injection [Vyxeos] SBDFP · 2654616
Vyxeos Injectable Product SBDG · 1942747
Vyxeos BN · 1942744

📦 FDA Products & Package NDCs

1 product · 2 package NDCs

2 package NDCs map to RxCUI 1942743 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
68727-0745-01	20 mL in 1 VIAL (68727-745-01)	VYXEOS	Jazz Pharmaceuticals, Inc.	2017-08-03
68727-0745-02	40 mL in 1 CARTON (68727-745-02)	VYXEOS	Jazz Pharmaceuticals, Inc.	2017-08-03

Observed labelers: Jazz Pharmaceuticals, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J9153	Inj daunorubicin, cytarabine	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.